Delivra Health Brands Enters Into Sales and Distribution Agreement With Casey's, a Leading Convenience Store Chain, to Increase North American Distribution Points for Dream Water and Announces Grant of Incentive Stock Options
Delivra Health Brands Enters Into Sales and Distribution Agreement With Casey's, a Leading Convenience Store Chain, to Increase North American Distribution Points for Dream Water and Announces Grant of Incentive Stock Options
Vancouver, British Columbia--(Newsfile Corp. - November 2, 2022) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods ("CPG") leader uniquely positioned in the health and wellness sector, announced today that its wholly-owned subsidiary, Dream Products USA Inc., has further expanded its distribution in the United States with the signing of a sales and distribution agreement (the "Agreement") dated November 1, 2022 with Casey's General Stores ("Casey's"), a leading North American convenience store chain with over 2,400 locations.
温哥華，不列顛哥倫比亞省-(Newsfile Corp.-2022年11月2日)-Delivra Health Brands Inc.(TSXV：DHB)(OTCQB：DHBUF)(“Delivra Health“或”公司)，消費包裝商品(CPG)今天宣佈，其全資子公司Dream Products USA Inc.簽署了一項銷售和分銷協議，進一步擴大了其在美國的分銷協議日期為2022年11月1日，凱西百貨公司("凱西的)，一家北美領先的便利店連鎖店，擁有2,400多家門店。
Gord Davey, President and CEO of Delivra Health said, "Further to our growth objectives, our team has focused on the development of new emerging channel partners, which we have achieved through the signing of the Agreement, extending distribution to over 2,400 new Casey's locations. These relationships, complemented by our existing partners and network in North America, will accelerate distribution, brand awareness and product trial. This expanded network is exciting news as it will foster additional growth of the Company's existing CPG brand, Dream WaterTM , and set the Company up for future success with our anticipated line extensions of both cannabis infused and non-infused products."
Delivra Health首席執行官兼首席執行官戈德·戴維表示：“為了實現我們的增長目標，我們的團隊專注於開發新的新興渠道合作伙伴，這是我們通過簽署協議實現的，將分銷擴展到2,400多個新的Casey‘s門店。這些關係，加上我們在北美的現有合作伙伴和網絡，將加快分銷、品牌知名度和產品試驗。這個擴大的網絡是令人興奮的消息，因為它將促進公司現有的CPG品牌Dream Water的進一步增長TM，並通過我們預期的大麻注入和非注入產品的生產線擴展，為公司未來的成功做好準備。“
For more information about Casey's, please visit their website at: .
有關Casey‘s的更多信息，請訪問他們的網站：。
In addition to the above, the Company announces it has granted certain directors, officers and employees of the Company an aggregate of 4,900,000 options to purchase common shares in the capital of the Company pursuant to its share option plan. The options are exercisable at a price of $0.05 per common share and will have a term of five years from the date of grant.
除上述事項外，本公司宣佈已根據其購股權計劃授予本公司若干董事、高級管理人員及僱員合共4,900,000份購股權，以購買本公司股本中的普通股。該等認購權可按每股普通股0.05美元的價格行使，有效期為五年，自授予之日起計。
About Delivra Health Brands Inc.
關於Delivra Health Brands Inc.
Helping people take control of their health with alternative wellness solutions is what energizes the Delivra Health team! The Delivra Health portfolio features innovative brands like Dream Water™ and LivRelief™, which deliver relief from common everyday issues like chronic pain, anxiety, and sleeplessness. Delivra Health products have allowed millions of customers to reclaim their mobility, energy, and in turn, quality of life. The websites of the Company's two subsidiaries are Dream Water™ and LivReliefTM. For more information, please visit .
幫助人們通過替代健康解決方案控制自己的健康是Delivra Health團隊的動力所在！德利夫拉健康產品組合以創新品牌為特色，如夢想之水™和生活救濟™，這些品牌可以緩解常見的日常問題，如慢性疼痛、焦慮和失眠。Delivra保健產品讓數百萬客户重新獲得了他們的機動性、能量和生活質量。該公司的兩個子公司的網站是 Dream Water™和 LivRelipmentTM。欲瞭解更多信息，請訪問 。
Cautionary Note Regarding Forward-Looking Statements
有關前瞻性陳述的注意事項
This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates, and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements include, among other things, statements with respect to the Company's growth objectives, new channel and distribution partners, acceleration of distribution, brand awareness, and product trial and future line extensions of cannabis infused and non-infused products.
本新聞稿包含適用於加拿大證券法的“前瞻性信息”和“前瞻性陳述”(統稱為“前瞻性陳述”)。除有關歷史事實的陳述外，所有陳述均為前瞻性陳述，均基於截至本新聞稿發佈之日的預期、估計和預測。任何涉及關於預測、期望、信念、計劃、預測、目標、假設、未來事件或業績的討論的陳述(經常但不總是使用諸如“預期”或“不預期”、“預計”、“預期”或“不預期”、“計劃”、“預算”、“預定”、“預測”、“估計”、“相信”或“打算”或這些詞語和短語的變體，或陳述某些行動、事件或結果“可能”或“可能”、“將”，“可能”或“將”被視為發生或實現)不是歷史事實的陳述，可能是前瞻性陳述。在本新聞稿中，前瞻性陳述包括有關公司的增長目標、新的渠道和分銷合作伙伴、加速分銷、品牌知名度以及注入和非注入大麻產品的產品試驗和未來生產線擴展等方面的陳述。
These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: implications of the COVID-19 pandemic on the Company's operations; fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the cannabis markets where the Company operates; changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; employee relations and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution, and sale of cannabis and cannabis-related products in the markets where the Company operates. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.
這些前瞻性陳述是基於作出這些陳述時公司管理層的合理假設和估計。由於前瞻性陳述涉及已知和未知的風險、不確定因素和其他因素，可能導致公司的實際結果、業績或成就與此類前瞻性陳述明示或暗示的未來結果、業績或成就大不相同，因此未來的實際結果可能大不相同。這些因素包括：新冠肺炎疫情對公司業務的影響；宏觀經濟形勢的總體波動；證券市場的波動；對公司經營的大麻市場規模的預期；消費者習慣的變化；公司成功實現業務目標的能力；擴張計劃；政治和社會不確定性；無法獲得足夠的保險以承保風險和危害；員工關係；以及存在可能對公司經營市場的大麻及大麻相關產品的種植、生產、分銷和銷售施加限制的法律法規。儘管本新聞稿中包含的前瞻性陳述是基於公司管理層認為或當時被認為是合理假設的，但公司不能向股東保證實際結果將與這些前瞻性陳述一致，因為可能存在其他因素導致結果與預期、估計或預期的結果不一致。讀者不應過分依賴本新聞稿中包含的前瞻性陳述和信息。如果信念、意見、預測或其他因素髮生變化，公司不承擔更新前瞻性陳述的義務, 除法律另有規定外。
Additional information regarding this and other risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's annual information form dated March 2, 2021, and under the heading "Risks and Uncertainties" in the Company's management's discussion and analysis dated October 28, 2022, for the year ended June 30, 2022, filed under the Company's profile on SEDAR at .
有關這一風險和與公司業務有關的其他風險和不確定因素的更多信息，載於公司日期為2021年3月2日的公司年度信息表中的“風險因素”標題，以及公司管理層於2022年10月28日提交的截至2022年6月30日的年度討論和分析中的“風險和不確定因素”標題下。
Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accept responsibility for the adequacy or accuracy of this release.
多倫多證券交易所及其監管服務提供商(該術語在多倫多證券交易所-V的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。
Investor Relations:
Jack Tasse
Chief Financial Officer
IR@delivrahealth.com
1-877-915-7934
投資者關係：
傑克·塔斯
首席財務官
郵箱：ir@delivraHealth.com
1-877-915-7934
To view the source version of this press release, please visit
要查看本新聞稿的源版本，請訪問
譯文內容由第三人軟體翻譯。